The onset of AAA is driven by multiple genetic factors, including the low-density lipoprotein receptor, matrix metalloproteinases (MMPs), particularly MMP2 and MMP9, transforming growth factor-beta1 (TGFβ1), and angiotensin II (Ang II) [8]. Here, MMP9 is linked to triple-A syndrome.